IgG antibodies to HTLV-III associated antigens in patients with AIDS and at risk for AIDS in The Netherlands. NLM AIDSLINE Important note: Information in this article was accurate in 1987. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


IgG antibodies to HTLV-III associated antigens in patients with AIDS and at risk for AIDS in The Netherlands.

AIDS Res. 1983-84;1(4):231-6. Unique Identifier : AIDSLINE MED/87000001
Goudsmit J; Tersmette T; Kabel P; Miedema F; Melief C

Abstract: Thirty-nine homosexual males, 11 of whom suffered from AIDS and 13 from Lymphadenopathy Syndrome (LAS), 18 healthy hemophiliacs and 12 healthy blood donors, not belonging to any AIDS risk group, were tested for IgG antibodies to Human T-lymphotropic retrovirus type III (HTLV-III) by indirect immunofluorescence. All tested people were from the area of Amsterdam or from elsewhere in The Netherlands. Five of 11 AIDS patients, 8 of 13 LAS patients and 5 of 15 healthy homosexuals had antibodies to HTLV-III. Five of 18 healthy hemophiliacs were seropositive for HTLV-III. None of the 12 blood donors was seropositive for HTLV-III.
Keywords: Acquired Immunodeficiency Syndrome/ETIOLOGY/*IMMUNOLOGY Antibodies, Viral/*ANALYSIS Fluorescent Antibody Technique Hemophilia/IMMUNOLOGY Homosexuality Human IgG/*ANALYSIS Lymphatic Diseases/ETIOLOGY/*IMMUNOLOGY Male Netherlands Retroviridae Infections/EPIDEMIOLOGY/*IMMUNOLOGY Risk JOURNAL ARTICLE

KWDacquiredimmunodeficiencysyndrome/etiology/KWDimmunologyantibodies,viral/KWDanalysisfluorescentantibodytechniquehemophilia/immunologyhomosexualityhumanigg/KWDanalysislymphaticdiseases/etiology/KWDimmunologymalenetherlandsretroviridaeinfections/epidemiology/KWDimmunologyriskjournalarticle
870130
M8710253

Copyright © 1987 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1987. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1987. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .